{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T20:05:14Z","timestamp":1772136314482,"version":"3.50.1"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T00:00:00Z","timestamp":1752883200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T00:00:00Z","timestamp":1752883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"European College of veterinary Ophthalmologists"},{"name":"British Association of Veterinary Ophthalmologists"},{"name":"Easter Bush Collaborative Seed Corn Grant"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Feline diffuse iris melanoma (FDIM) is the most common primary ocular tumour in cats, with metastatic disease occurring in 19\u201363% of patients. Greater intraocular invasion correlates with increased mortality. No effective therapeutics exist for metastatic FDIM, partly due to a lack of known molecular targets associated with aggressive tumour behaviour. Here, we define the transcriptomic landscape of FDIM in treatment-na\u00efve cats using bulk RNA sequencing on laser capture microdissection and core biopsy specimens from formalin-fixed paraffin-embedded tissue. Samples included \u2018iris melanosis\u2019 (dysplastic melanocytes confined to the anterior iris; n\u2009=\u20097), \u2018early FDIM\u2019 (neoplastic melanocytes confined to the iris stroma; n\u2009=\u200913), and \u2018late FDIM\u2019 (neoplastic infiltration into the ciliary body and sclera; n\u2009=\u200913). Iris melanosis exhibited genetic overlap with early FDIM, supporting its reclassification as \u2018melanoma in situ\u2019. Early FDIM showed upregulation of genes linked to tumour initiation, immune recruitment, and motility (e.g.,\n                    <jats:italic>STOX1, PEG3, XIAP, MCAM, VIM<\/jats:italic>\n                    ). Late FDIM exhibited immune microenvironment remodelling, immune evasion, and apoptosis inhibition (e.g.,\n                    <jats:italic>BIRC2, BIRC5, CCL2, HAVCR2<\/jats:italic>\n                    ), with downregulation of\n                    <jats:italic>FOX1, FOXC2<\/jats:italic>\n                    , and\n                    <jats:italic>SOX11<\/jats:italic>\n                    . These results provide critical biomarkers of disease severity, which may aid in the development of more accurate prognostic tests and more effective targeted therapies for FDIM.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-09632-5","type":"journal-article","created":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T06:39:10Z","timestamp":1752907150000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Uncovering the molecular signature of feline diffuse iris melanoma through transcriptomic analysis of disease severity"],"prefix":"10.1038","volume":"15","author":[{"given":"D.","family":"Kayes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Blacklock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"McGeachan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Scurrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Donnelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Fawkes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Meynert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Becher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Pittaway","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Fricker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Tetas","family":"Pont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Su\u00e1rez-Bonnet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. L. Bowlt","family":"Blacklock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,19]]},"reference":[{"key":"9632_CR1","volume-title":"Veterinary Ocular Pathology: A Comparative Review","author":"RR Dubielzig","year":"2010","unstructured":"Dubielzig, R. R. Veterinary Ocular Pathology: A Comparative Review (Elsevier, 2010)."},{"issue":"6","key":"9632_CR2","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/j.1463-5224.2006.00479.x","volume":"9","author":"BH Grahn","year":"2006","unstructured":"Grahn, B. H. et al. Classification of feline intraocular neoplasms based on morphology, histochemical staining, and immunohistochemical labeling. Vet. Ophthalmol. 9(6), 395\u2013403 (2006).","journal-title":"Vet. Ophthalmol."},{"issue":"2","key":"9632_CR3","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1177\/030098588802500201","volume":"25","author":"AK Patnaik","year":"1988","unstructured":"Patnaik, A. K. & Mooney, S. Feline melanoma: A comparative study of ocular, oral, and dermal neoplasms. Vet. Pathol. 25(2), 105\u2013112 (1988).","journal-title":"Vet. Pathol."},{"issue":"2","key":"9632_CR4","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/vop.12718","volume":"23","author":"HJ Featherstone","year":"2020","unstructured":"Featherstone, H. J. et al. Iris biopsy to investigate feline iris hyperpigmentation. Vet. Ophthalmol. 23(2), 269\u2013276 (2020).","journal-title":"Vet. Ophthalmol."},{"issue":"2","key":"9632_CR5","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3390\/vetsci9020046","volume":"9","author":"D Kayes","year":"2022","unstructured":"Kayes, D. & Blacklock, B. Feline uveal melanoma review: Our current understanding and recent research advances. Vet. Sci. 9(2), 46 (2022).","journal-title":"Vet. Sci."},{"issue":"1","key":"9632_CR6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1046\/j.1463-5224.1998.00006.x","volume":"1","author":"JB Kalishman","year":"1998","unstructured":"Kalishman, J. B. et al. A matched observational study of survival in cats with enucleation due to diffuse iris melanoma. Vet. Ophthalmol. 1(1), 25\u201329 (1998).","journal-title":"Vet. Ophthalmol."},{"issue":"Suppl 1","key":"9632_CR7","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/vop.12344","volume":"19","author":"KT Wiggans","year":"2016","unstructured":"Wiggans, K. T. et al. Histologic and immunohistochemical predictors of clinical behavior for feline diffuse iris melanoma. Vet. Ophthalmol. 19(Suppl 1), 44\u201355 (2016).","journal-title":"Vet. Ophthalmol."},{"issue":"1","key":"9632_CR8","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2460\/javma.23.07.0387","volume":"262","author":"AA Fuchs","year":"2024","unstructured":"Fuchs, A. A. et al. Diode laser ablation of progressive pigmented iris lesions in 317 cats (356 eyes) appears overall safe and effective in decreasing progression of iris pigmentation. J. Am. Vet. Med. Assoc. 262(1), 117\u2013124 (2024).","journal-title":"J. Am. Vet. Med. Assoc."},{"issue":"4","key":"9632_CR9","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1111\/vco.12285","volume":"15","author":"JG Rushton","year":"2017","unstructured":"Rushton, J. G. et al. Mutation analysis and gene expression profiling of ocular melanomas in cats. Vet. Comp. Oncol. 15(4), 1403\u20131416 (2017).","journal-title":"Vet. Comp. Oncol."},{"issue":"11","key":"9632_CR10","doi-asserted-by":"publisher","first-page":"4651","DOI":"10.1167\/iovs.03-0538","volume":"44","author":"E Kujala","year":"2003","unstructured":"Kujala, E., Makitie, T. & Kivela, T. Very long-term prognosis of patients with malignant uveal melanoma. Invest. Ophthalmol. Vis. Sci. 44(11), 4651\u20134659 (2003).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"9632_CR11","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1136\/bjophthalmol-2016-309034","volume":"101","author":"RD Carvajal","year":"2017","unstructured":"Carvajal, R. D. et al. Metastatic disease from uveal melanoma: Treatment options and future prospects. Br. J. Ophthalmol. 101(1), 38\u201344 (2017).","journal-title":"Br. J. Ophthalmol."},{"issue":"1","key":"9632_CR12","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41572-020-0158-0","volume":"6","author":"MJ Jager","year":"2020","unstructured":"Jager, M. J. et al. Uveal melanoma. Nat. Rev. Dis. Prim. 6(1), 24 (2020).","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"12","key":"9632_CR13","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1001\/archopht.123.12.1639","volume":"123","author":"M Diener-West","year":"2005","unstructured":"Diener-West, M. et al. Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group Report No. 26. Arch. Ophthalmol. 123(12), 1639\u20131643 (2005).","journal-title":"Arch. Ophthalmol."},{"issue":"1","key":"9632_CR14","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jaapos.2011.10.012","volume":"16","author":"CL Shields","year":"2012","unstructured":"Shields, C. L. et al. Iris melanoma: Features and prognosis in 317 children and adults. J AAPOS 16(1), 10\u201316 (2012).","journal-title":"J AAPOS"},{"issue":"1","key":"9632_CR15","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.clindermatol.2023.10.009","volume":"42","author":"E Cherkas","year":"2024","unstructured":"Cherkas, E. et al. Iris melanoma: Review of clinical features, risks, management, and outcomes. Clin. Dermatol. 42(1), 62\u201370 (2024).","journal-title":"Clin. Dermatol."},{"issue":"1","key":"9632_CR16","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12867-017-0099-7","volume":"18","author":"P Amini","year":"2017","unstructured":"Amini, P. et al. An optimised protocol for isolation of RNA from small sections of laser-capture microdissected FFPE tissue amenable for next-generation sequencing. BMC Mol. Biol. 18(1), 22 (2017).","journal-title":"BMC Mol. Biol."},{"issue":"3","key":"9632_CR17","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s41587-020-0439-x","volume":"38","author":"PA Ewels","year":"2020","unstructured":"Ewels, P. A. et al. The nf-core framework for community-curated bioinformatics pipelines. Nat. Biotechnol. 38(3), 276\u2013278 (2020).","journal-title":"Nat. Biotechnol."},{"issue":"4","key":"9632_CR18","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/nbt.3820","volume":"35","author":"P Di Tommaso","year":"2017","unstructured":"Di Tommaso, P. et al. Nextflow enables reproducible computational workflows. Nat. Biotechnol. 35(4), 316\u2013319 (2017).","journal-title":"Nat. Biotechnol."},{"issue":"6","key":"9632_CR19","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/bioinformatics\/btq033","volume":"26","author":"AR Quinlan","year":"2010","unstructured":"Quinlan, A. R. & Hall, I. M. BEDTools: A flexible suite of utilities for comparing genomic features. Bioinformatics 26(6), 841\u2013842 (2010).","journal-title":"Bioinformatics"},{"issue":"17","key":"9632_CR20","doi-asserted-by":"publisher","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","volume":"34","author":"S Chen","year":"2018","unstructured":"Chen, S. et al. fastp: An ultra-fast all-in-one FASTQ preprocessor. Bioinformatics 34(17), i884\u2013i890 (2018).","journal-title":"Bioinformatics"},{"key":"9632_CR21","unstructured":"Simon, A. FASTQC: A quality control tool for high throughput sequence data. (2010)."},{"issue":"19","key":"9632_CR22","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1093\/bioinformatics\/btw354","volume":"32","author":"P Ewels","year":"2016","unstructured":"Ewels, P. et al. MultiQC: Summarize analysis results for multiple tools and samples in a single report. Bioinformatics 32(19), 3047\u20133048 (2016).","journal-title":"Bioinformatics"},{"issue":"4","key":"9632_CR23","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nmeth.4197","volume":"14","author":"R Patro","year":"2017","unstructured":"Patro, R. et al. Salmon provides fast and bias-aware quantification of transcript expression. Nat. Methods 14(4), 417\u2013419 (2017).","journal-title":"Nat. Methods"},{"issue":"1","key":"9632_CR24","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: Ultrafast universal RNA-seq aligner. Bioinformatics 29(1), 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"9632_CR25","unstructured":"Krueger, F. FelixKrueger\/TrimGalore. A wrapper around Cutadapt and FastQC to consistently apply adapter and quality trimming to FastQ files, with extra functionality for RRBS data. (2023)."},{"issue":"16","key":"9632_CR26","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. et al. The sequence alignment\/map format and SAMtools. Bioinformatics 25(16), 2078\u20132079 (2009).","journal-title":"Bioinformatics"},{"issue":"3","key":"9632_CR27","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkaa1146","volume":"49","author":"Z Gu","year":"2021","unstructured":"Gu, Z., Schlesner, M. & Hubschmann, D. cola: An R\/Bioconductor package for consensus partitioning through a general framework. Nucleic Acids Res. 49(3), e15 (2021).","journal-title":"Nucleic Acids Res."},{"issue":"12","key":"9632_CR28","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15(12), 550 (2014).","journal-title":"Genome Biol."},{"issue":"12","key":"9632_CR29","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1093\/bioinformatics\/bty895","volume":"35","author":"A Zhu","year":"2019","unstructured":"Zhu, A., Ibrahim, J. G. & Love, M. I. Heavy-tailed prior distributions for sequence count data: Removing the noise and preserving large differences. Bioinformatics 35(12), 2084\u20132092 (2019).","journal-title":"Bioinformatics"},{"issue":"2","key":"9632_CR30","first-page":"275","volume":"18","author":"M Stephens","year":"2017","unstructured":"Stephens, M. False discovery rates: A new deal. Biostatistics 18(2), 275\u2013294 (2017).","journal-title":"Biostatistics"},{"issue":"7","key":"9632_CR31","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nmeth.3885","volume":"13","author":"N Ignatiadis","year":"2016","unstructured":"Ignatiadis, N. et al. Data-driven hypothesis weighting increases detection power in genome-scale multiple testing. Nat. Methods 13(7), 577\u2013580 (2016).","journal-title":"Nat. Methods"},{"issue":"16","key":"9632_CR32","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.1093\/bioinformatics\/bti525","volume":"21","author":"S Durinck","year":"2005","unstructured":"Durinck, S. et al. BioMart and Bioconductor: A powerful link between biological databases and microarray data analysis. Bioinformatics 21(16), 3439\u20133440 (2005).","journal-title":"Bioinformatics"},{"key":"9632_CR33","unstructured":"https:\/\/volcano.bioinformagic.tools\/. 13th February 2025]."},{"issue":"4","key":"9632_CR34","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","volume":"30","author":"A Kramer","year":"2014","unstructured":"Kramer, A. et al. Causal analysis approaches in ingenuity pathway analysis. Bioinformatics 30(4), 523\u2013530 (2014).","journal-title":"Bioinformatics"},{"issue":"1","key":"9632_CR35","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28(1), 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"9632_CR36","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28(11), 1947\u20131951 (2019).","journal-title":"Protein Sci."},{"issue":"D1","key":"9632_CR37","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M. et al. KEGG: Biological systems database as a model of the real world. Nucleic Acids Res. 53(D1), D672\u2013D677 (2025).","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"9632_CR38","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s13402-019-00427-1","volume":"42","author":"O Ayachi","year":"2019","unstructured":"Ayachi, O. et al. The X-linked inhibitor of apoptosis protein (XIAP) is involved in melanoma invasion by regulating cell migration and survival. Cell Oncol. (Dordr) 42(3), 319\u2013329 (2019).","journal-title":"Cell Oncol. (Dordr)"},{"issue":"2","key":"9632_CR39","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3390\/cancers10020052","volume":"10","author":"J Roche","year":"2018","unstructured":"Roche, J. The epithelial-to-mesenchymal transition in cancer. Cancers 10(2), 52 (2018).","journal-title":"Cancers"},{"issue":"3","key":"9632_CR40","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3390\/cancers15030775","volume":"15","author":"C Barbagallo","year":"2023","unstructured":"Barbagallo, C. et al. Genetics and RNA regulation of uveal melanoma. Cancers (Basel) 15(3), 775 (2023).","journal-title":"Cancers (Basel)"},{"key":"9632_CR41","doi-asserted-by":"publisher","first-page":"6001","DOI":"10.2147\/OTT.S208060","volume":"12","author":"T Zhou","year":"2019","unstructured":"Zhou, T. et al. The role of PEG3 in the occurrence and prognosis of colon cancer. Onco. Targets Ther. 12, 6001\u20136012 (2019).","journal-title":"Onco. Targets Ther."},{"issue":"1","key":"9632_CR42","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s13046-021-01947-1","volume":"40","author":"A Tosi","year":"2021","unstructured":"Tosi, A. et al. The immune cell landscape of metastatic uveal melanoma correlates with overall survival. J. Exp. Clin. Cancer Res. 40(1), 154 (2021).","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"13","key":"9632_CR43","doi-asserted-by":"publisher","first-page":"3094","DOI":"10.3390\/cancers14133094","volume":"14","author":"Y Fu","year":"2022","unstructured":"Fu, Y., Xiao, W. & Mao, Y. Recent advances and challenges in uveal melanoma immunotherapy. Cancers (Basel) 14(13), 3094 (2022).","journal-title":"Cancers (Basel)"},{"issue":"5\u20136","key":"9632_CR44","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1159\/000334576","volume":"4","author":"IH Bronkhorst","year":"2012","unstructured":"Bronkhorst, I. H. & Jager, M. J. Uveal melanoma: The inflammatory microenvironment. J. Innate Immun. 4(5\u20136), 454\u2013462 (2012).","journal-title":"J. Innate Immun."},{"issue":"10","key":"9632_CR45","doi-asserted-by":"publisher","DOI":"10.4161\/21624011.2014.947169","volume":"8","author":"PL Triozzi","year":"2019","unstructured":"Triozzi, P. L. et al. Molecular profiling of primary uveal melanomas with tumor-infiltrating lymphocytes. Oncoimmunology 8(10), e947169 (2019).","journal-title":"Oncoimmunology"},{"key":"9632_CR46","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.biochi.2023.04.013","volume":"212","author":"S Liau","year":"2023","unstructured":"Liau, S. et al. An update on inflammation in uveal melanoma. Biochimie 212, 114\u2013122 (2023).","journal-title":"Biochimie"},{"issue":"9","key":"9632_CR47","doi-asserted-by":"publisher","first-page":"5370","DOI":"10.1167\/iovs.11-9280","volume":"53","author":"IH Bronkhorst","year":"2012","unstructured":"Bronkhorst, I. H. et al. Different subsets of tumor-infiltrating lymphocytes correlate with macrophage influx and monosomy 3 in uveal melanoma. Invest. Ophthalmol. Vis. Sci. 53(9), 5370\u20135378 (2012).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"9632_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.972664","volume":"13","author":"H Li","year":"2022","unstructured":"Li, H. et al. Differential expression of HAVCR2 gene in pan-cancer: A potential biomarker for survival and immunotherapy. Front. Genet. 13, 972664 (2022).","journal-title":"Front. Genet."},{"issue":"1","key":"9632_CR49","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12943-022-01672-z","volume":"21","author":"L Tong","year":"2022","unstructured":"Tong, L. et al. NK cells and solid tumors: Therapeutic potential and persisting obstacles. Mol. Cancer 21(1), 206 (2022).","journal-title":"Mol. Cancer"},{"issue":"1","key":"9632_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0210276","volume":"14","author":"MS Basile","year":"2019","unstructured":"Basile, M. S. et al. Differential modulation and prognostic values of immune-escape genes in uveal melanoma. PLoS ONE 14(1), e0210276 (2019).","journal-title":"PLoS ONE"},{"issue":"1","key":"9632_CR51","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3390\/cancers14010096","volume":"14","author":"NJ Lamas","year":"2021","unstructured":"Lamas, N. J. et al. Prognostic biomarkers in uveal melanoma: The status quo, recent advances and future directions. Cancers 14(1), 96 (2021).","journal-title":"Cancers"},{"issue":"8","key":"9632_CR52","doi-asserted-by":"publisher","first-page":"5169","DOI":"10.1167\/iovs.14-14394","volume":"55","author":"T Jehs","year":"2014","unstructured":"Jehs, T. et al. Inflammation-induced chemokine expression in uveal melanoma cell lines stimulates monocyte chemotaxis. Invest. Ophthalmol. Vis. Sci. 55(8), 5169\u20135175 (2014).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"9632_CR53","doi-asserted-by":"publisher","DOI":"10.1017\/erm.2022.28","volume":"24","author":"E Mergia Terefe","year":"2022","unstructured":"Mergia Terefe, E. et al. Roles of CCR10\/CCL27-CCL28 axis in tumour development: Mechanisms, diagnostic and therapeutic approaches, and perspectives. Expert Rev. Mol. Med. 24, e37 (2022).","journal-title":"Expert Rev. Mol. Med."},{"issue":"1","key":"9632_CR54","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.1038\/s41467-024-46906-4","volume":"15","author":"S Leonard-Murali","year":"2024","unstructured":"Leonard-Murali, S. et al. Uveal melanoma immunogenomics predict immunotherapy resistance and susceptibility. Nat. Commun. 15(1), 2863 (2024).","journal-title":"Nat. Commun."},{"key":"9632_CR55","doi-asserted-by":"publisher","first-page":"175883592311601","DOI":"10.1177\/17588359231160140","volume":"15","author":"S Howlett","year":"2023","unstructured":"Howlett, S. et al. Tebentafusp: A first-in-class treatment for metastatic uveal melanoma. Ther. Adv. Med. Oncol. 15, 175883592311601 (2023).","journal-title":"Ther. Adv. Med. Oncol."},{"issue":"7","key":"9632_CR56","doi-asserted-by":"publisher","first-page":"971","DOI":"10.3390\/cancers11070971","volume":"11","author":"BE Damato","year":"2019","unstructured":"Damato, B. E. et al. Tebentafusp: T cell redirection for the treatment of metastatic uveal melanoma. Cancers (Basel) 11(7), 971 (2019).","journal-title":"Cancers (Basel)"},{"issue":"13","key":"9632_CR57","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1056\/NEJMoa2103485","volume":"385","author":"P Nathan","year":"2021","unstructured":"Nathan, P. et al. Overall survival benefit with Tebentafusp in metastatic uveal melanoma. N. Engl. J. Med. 385(13), 1196\u20131206 (2021).","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"9632_CR58","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1136\/gutjnl-2015-310514","volume":"66","author":"X Li","year":"2017","unstructured":"Li, X. et al. Targeting of tumour-infiltrating macrophages via CCL2\/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma. Gut 66(1), 157\u2013167 (2017).","journal-title":"Gut"},{"issue":"1","key":"9632_CR59","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/s42003-020-01441-y","volume":"3","author":"MM Tu","year":"2020","unstructured":"Tu, M. M. et al. Inhibition of the CCL2 receptor, CCR2, enhances tumor response to immune checkpoint therapy. Commun. Biol. 3(1), 720 (2020).","journal-title":"Commun. Biol."},{"issue":"2","key":"9632_CR60","doi-asserted-by":"publisher","first-page":"89","DOI":"10.36401\/JIPO-23-4","volume":"7","author":"B Duong","year":"2024","unstructured":"Duong, B., Banskota, P. & Falchook, G. S. T cell immunoglobulin and mucin domain containing protein 3 (TIM-3) inhibitors in oncology clinical trials: A review. J. Immunother. Precis. Oncol. 7(2), 89\u201396 (2024).","journal-title":"J. Immunother. Precis. Oncol."},{"issue":"3","key":"9632_CR61","doi-asserted-by":"publisher","first-page":"645","DOI":"10.3390\/ijms18030645","volume":"18","author":"W Du","year":"2017","unstructured":"Du, W. et al. TIM-3 as a target for cancer immunotherapy and mechanisms of action. Int. J. Mol. Sci. 18(3), 645 (2017).","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"9632_CR62","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1080\/02713680802382989","volume":"33","author":"M Lederman","year":"2008","unstructured":"Lederman, M. et al. Inhibitor of apoptosis proteins gene expression and its correlation with prognostic factors in primary and metastatic uveal melanoma. Curr. Eye Res. 33(10), 876\u2013884 (2008).","journal-title":"Curr. Eye Res."},{"issue":"1","key":"9632_CR63","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1186\/s13046-019-1362-1","volume":"38","author":"F Li","year":"2019","unstructured":"Li, F., Aljahdali, I. & Ling, X. Cancer therapeutics using survivin BIRC5 as a target: What can we do after over two decades of study?. J. Exp. Clin. Cancer Res. 38(1), 368 (2019).","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"8","key":"9632_CR64","doi-asserted-by":"publisher","first-page":"8165","DOI":"10.18632\/oncotarget.22742","volume":"9","author":"FA Elian","year":"2018","unstructured":"Elian, F. A., Yan, E. & Walter, M. A. FOXC1, the new player in the cancer sandbox. Oncotarget 9(8), 8165\u20138178 (2018).","journal-title":"Oncotarget"},{"issue":"2","key":"9632_CR65","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3390\/cancers11020184","volume":"11","author":"LN Gilding","year":"2019","unstructured":"Gilding, L. N. & Somervaille, T. C. P. The diverse consequences of FOXC1 deregulation in cancer. Cancers 11(2), 184 (2019).","journal-title":"Cancers"},{"issue":"12","key":"9632_CR66","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1038\/ejhg.2009.93","volume":"17","author":"Z T\u00fcmer","year":"2009","unstructured":"T\u00fcmer, Z. & Bach-Holm, D. Axenfeld-Rieger syndrome and spectrum of PITX2 and FOXC1 mutations. Eur. J. Hum. Genet. 17(12), 1527\u20131539 (2009).","journal-title":"Eur. J. Hum. Genet."},{"issue":"28","key":"9632_CR67","doi-asserted-by":"publisher","first-page":"3957","DOI":"10.1038\/onc.2017.48","volume":"36","author":"B Han","year":"2017","unstructured":"Han, B. et al. FOXC1: An emerging marker and therapeutic target for cancer. Oncogene 36(28), 3957\u20133963 (2017).","journal-title":"Oncogene"},{"issue":"12","key":"9632_CR68","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1177\/1758834017742576","volume":"9","author":"Z Yang","year":"2017","unstructured":"Yang, Z. et al. FOXC1 in cancer development and therapy: Deciphering its emerging and divergent roles. Ther. Adv. Med. Oncol. 9(12), 797\u2013816 (2017).","journal-title":"Ther. Adv. Med. Oncol."},{"key":"9632_CR69","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.cca.2018.01.019","volume":"479","author":"T Wang","year":"2018","unstructured":"Wang, T. et al. Emerging roles and mechanisms of FOXC2 in cancer. Clin. Chim Acta 479, 84\u201393 (2018).","journal-title":"Clin. Chim Acta"},{"issue":"13","key":"9632_CR70","first-page":"5057","volume":"55","author":"S Bakalian","year":"2014","unstructured":"Bakalian, S. et al. The expression of FoxC1 in uveal melanoma. Invest. Ophthalmol. Vis. Sci. 55(13), 5057\u20135057 (2014).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"9632_CR71","doi-asserted-by":"publisher","first-page":"175883591985344","DOI":"10.1177\/1758835919853449","volume":"11","author":"Z Yang","year":"2019","unstructured":"Yang, Z. et al. SOX11: friend or foe in tumor prevention and carcinogenesis?. Ther. Adv. Med. Oncol. 11, 1758835919853449 (2019).","journal-title":"Ther. Adv. Med. Oncol."},{"issue":"8","key":"9632_CR72","doi-asserted-by":"publisher","first-page":"6133","DOI":"10.1007\/s13277-015-3296-3","volume":"36","author":"Z Yao","year":"2015","unstructured":"Yao, Z. et al. The role of tumor suppressor gene SOX11 in prostate cancer. Tumour Biol. 36(8), 6133\u20136138 (2015).","journal-title":"Tumour Biol."},{"key":"9632_CR73","doi-asserted-by":"crossref","unstructured":"Harbour, J. W. & Chen, R. The DecisionDx-UM gene expression profile test provides risk stratification and individualized patient care in uveal melanoma. PLoS Curr. 5 (2013).","DOI":"10.1371\/currents.eogt.af8ba80fc776c8f1ce8f5dc485d4a618"},{"key":"9632_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/5325762","volume":"2016","author":"KM Plasseraud","year":"2016","unstructured":"Plasseraud, K. M. et al. Clinical performance and management outcomes with the DecisionDx-UM gene expression profile test in a prospective multicenter study. J. Oncol. 2016, 1\u20139 (2016).","journal-title":"J. Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09632-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09632-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09632-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T15:43:53Z","timestamp":1757259833000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09632-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,19]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9632"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-09632-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6228571\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,19]]},"assertion":[{"value":"14 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26218"}}